These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6958155)

  • 41. Effect of an inhibitor of TXA2 synthesis and of PGE2 on the formation of 12-L-hydroxy-5,8,10-heptadecatrienoic acid in human platelets.
    Vincent JE; Zijlstra FJ; van Vliet H
    Adv Prostaglandin Thromboxane Res; 1980; 6():463-6. PubMed ID: 7386279
    [No Abstract]   [Full Text] [Related]  

  • 42. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Blood platelets and the inflammatory process.
    Silver MJ; Smith JB; Ingerman CM
    Agents Actions; 1974 Oct; 4(4):233-40. PubMed ID: 4447066
    [No Abstract]   [Full Text] [Related]  

  • 44. [Changes in the initial platelet aggregation during storage of the platelet concentrate and exposure to the myeloperoxidase reaction products].
    Roshchupkin DI; Berzhitskaia VV; Sokolov AIu; Murina MA
    Biull Eksp Biol Med; 1997 Nov; 124(11):523-6. PubMed ID: 9471246
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical and pharmacological studies on various platelet inhibitors].
    Cronberg S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):834-8. PubMed ID: 94875
    [No Abstract]   [Full Text] [Related]  

  • 46. [Thrombocyte function in rabbits under fenoterol tocolysis (author's transl)].
    Ebert C; Tscherne B; Beller FK
    Zentralbl Gynakol; 1982; 104(9):526-32. PubMed ID: 7113518
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potentiation of antiaggregating effect of prostaglandins by alpha-tocopherol and quercetin.
    Mardla V; Kobzar G; Samel N
    Platelets; 2004 Aug; 15(5):319-24. PubMed ID: 15370103
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Platelets, thromboatherogenesis and ischemic cardiopathy].
    Batlouni M
    Arq Bras Cardiol; 1980 Jan; 34(1):45-52. PubMed ID: 6996649
    [No Abstract]   [Full Text] [Related]  

  • 49. [Blood platelet functional state and exposure to an aggregation inducer].
    Markosian RA; Popov EG; Radin AIu; Gabbasov ZA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1981; 4(2):47-51. PubMed ID: 7317159
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Role of blood platelets in inflammatory processes].
    Myśliwiec M; Myśliwiec B
    Pol Tyg Lek; 1982 Jul; 37(23):681-83. PubMed ID: 6184705
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effect of recombinant urokinase activator plasminogen on the platelet aggregation and increase of the intracellular calcium level].
    Zubkov AV; Bushueva TL; Minashkin MM; Gurskiĭ IaG; Men'shikov MIu
    Biull Eksp Biol Med; 1999 Sep; 128(9):339-43. PubMed ID: 10560061
    [No Abstract]   [Full Text] [Related]  

  • 52. Thromboxane and prostacyclin: implications for function and disease of the vasculature.
    McGiff JC
    Adv Intern Med; 1980; 25():199-216. PubMed ID: 6987841
    [No Abstract]   [Full Text] [Related]  

  • 53. [Platelets, prostaglandins, thromboses and cancer].
    Dufault C
    Union Med Can; 1984 Jun; 113(6):462-4. PubMed ID: 6485157
    [No Abstract]   [Full Text] [Related]  

  • 54. Platelet aggregating response to platelet activating factor participates in activation of the 12-lipoxygenase pathway in platelets from rabbits.
    Michibayashi T
    Int Angiol; 2002 Sep; 21(3):260-7. PubMed ID: 12384648
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preservation of platelet function and number by prostacyclin during cardiopulmonary bypass.
    Coppe D; Sobel M; Seamans L; Levine F; Salzman E
    J Thorac Cardiovasc Surg; 1981 Feb; 81(2):274-8. PubMed ID: 7005550
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Partial agonism of prostaglandin H2 analogs and 11-deoxy-prostaglandin F2 alpha to thromboxane-sensitive preparations.
    Jones RL; Wilson NH
    Adv Prostaglandin Thromboxane Res; 1980; 6():467-75. PubMed ID: 7386280
    [No Abstract]   [Full Text] [Related]  

  • 57. Pharmacological influence of nutmeg and nutmeg constituents on rabbit platelet function.
    Rasheed A; Laekeman GM; Vlietinck AJ; Janssens J; Hatfield G; Totte J; Herman AG
    Planta Med; 1984 Jun; 50(3):222-6. PubMed ID: 6541353
    [No Abstract]   [Full Text] [Related]  

  • 58. Prostaglandins in surgery.
    Minkes MS
    Surg Annu; 1981; 13():239-50. PubMed ID: 7025281
    [No Abstract]   [Full Text] [Related]  

  • 59. [Blood platelets, prostaglandin and complement interactions in inflammation].
    Myśliwiec M; Myśliwiec B
    Przegl Lek; 1982; 39(6):437-40. PubMed ID: 6753039
    [No Abstract]   [Full Text] [Related]  

  • 60. Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit.
    McManus LM; Hanahan DJ; Demopoulos CA; Pinckard RN
    J Immunol; 1980 Jun; 124(6):2919-24. PubMed ID: 7373056
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.